PatternsRadar
Sign in

SANOFISanofi India Limited

NSE
3,206.10INR+3.60 (+0.11%)Close · 20 Nov 2026
29 Oct 2026Last results
HealthcareSector
Pharmaceuticals & BiotechnologyIndustry
₹7,384 CrMarket cap
20.3P/E (TTM)
50.1%Delivery

Filings & corporate actions

81 results filed
CSV
Next results · Q3 FY27
Expected 23 Feb 2027 – 27 Feb 2027
Estimate: filed 54–58 days after quarter end, last 5 times
Dividend
₹75.00 per share · last 5 Nov 2026
2026
  • 5 NovdividendDividend · ₹75.00 per share · record 5 Nov 2026-2.2%
  • 29 OctresultsResults · Q2 FY27 · standalone+0.5%NSE
  • 20 OctshareholdingShareholding · 30 Sept 2026-1.8%NSE
  • 4 AugresultsResults · Q1 FY27 · standalone-1.9%NSE
  • 20 JulshareholdingShareholding · 30 Jun 2026-0.7%NSE
  • 28 AprresultsResults · Q4 FY26 · standalone-1.0%NSE
  • 22 AprdividendDividend · ₹48.00 per share-2.3%
  • 17 AprshareholdingShareholding · 31 Mar 20260.0%NSE
  • 25 FebresultsResults · Q3 FY26 · standalone-2.9%NSE
  • 20 JanshareholdingShareholding · 31 Dec 2025-0.6%NSE

Reaction to results · all yearsrose on day 0 in 32 of 80 CSV

QuarterFiledDay 0+5D+20DRel vol
Q2 FY2729 Oct 2026+0.5%+2.9%—10.5×
Q1 FY274 Aug 2026-1.9%-4.4%-7.0%1.1×
Q4 FY2628 Apr 2026-1.0%-2.3%-10.7%0.9×
Q3 FY2625 Feb 2026-2.9%-8.5%-22.4%10.8×
Q2 FY2629 Oct 2025+1.7%-1.9%-7.2%1.6×
Q1 FY2631 Jul 2025-4.7%-10.7%-12.2%2.6×
Q4 FY2514 May 2025+4.4%+3.6%+2.1%3.1×
Q3 FY2527 Feb 2025+0.5%+9.9%+17.2%30.3×
Q2 FY257 Nov 2024-1.6%-5.9%-4.8%0.4×
Q1 FY2526 Jul 2024-1.6%-4.0%+1.9%4.8×
Q4 FY2413 May 20240.0%+11.8%+25.7%2.7×
Q3 FY2423 Feb 2024-1.0%-4.5%-15.6%2.5×
Q2 FY248 Nov 2023+0.2%-0.9%+4.5%0.4×
Q1 FY2411 Aug 2023-2.7%-1.7%-3.0%3.3×
Q4 FY2311 May 2023+8.9%+12.2%+23.5%12.5×
Q3 FY2324 Feb 2023+5.4%+2.9%+1.2%10.2×
Q2 FY2310 Nov 2022-0.9%-1.4%+4.8%0.9×
Q1 FY2327 Jul 2022-0.3%+3.7%-3.2%1.5×
Q4 FY2227 Apr 2022-0.7%-1.2%-7.2%0.3×
Q3 FY2224 Feb 2022+0.6%-2.1%+4.5%2.4×
Q2 FY2227 Oct 2021+2.5%-0.6%+2.1%1.3×
Q1 FY2228 Jul 2021+1.6%+7.9%+9.0%11.0×
Q4 FY216 May 2021+0.6%+0.2%+0.3%1.5×
Q3 FY2124 Feb 2021-0.1%+2.0%-3.8%1.1×
Q2 FY2128 Oct 2020-1.6%-1.1%-1.6%0.8×
Q1 FY2129 Jul 2020+3.9%+9.2%+14.5%3.2×
Q4 FY2020 May 2020+1.1%+2.9%+6.4%0.9×
Q3 FY2026 Feb 2020+1.4%+5.9%-12.9%9.4×
Q2 FY2013 Nov 2019-1.1%+5.1%+5.1%1.1×
Q1 FY2030 Jul 2019-1.7%-1.8%-2.7%10.9×
Q4 FY199 May 2019-1.6%-2.2%-1.5%0.7×
Q3 FY196 Mar 2019-1.4%-1.2%+1.2%2.1×
Q2 FY1921 Nov 2018-1.0%+1.5%0.0%0.4×
Q1 FY197 Aug 20180.0%+2.9%+7.1%0.5×
Q4 FY1813 Jun 2018-2.2%-0.2%+4.9%0.3×
Q3 FY1826 Feb 2018+1.1%+2.7%+5.5%0.1×
Q2 FY182 Nov 2017+4.3%-1.2%-1.4%2.1×
Q1 FY1826 Jul 2017-0.1%-1.5%-5.9%0.3×
Q4 FY1711 May 2017-0.7%-1.9%-4.4%0.5×
Q3 FY1728 Feb 2017-0.9%+3.3%+14.4%3.7×
Q2 FY179 Nov 2016+2.0%+0.6%+3.9%1.1×
Q1 FY1728 Jul 2016-0.2%-2.1%-5.8%5.8×
Q4 FY1629 Apr 2016-0.2%-0.1%-3.1%0.3×
Q3 FY165 Feb 2016+1.7%-0.1%+5.8%1.0×
Q2 FY1614 Jan 2016+0.6%-2.3%-1.6%0.6×
Q1 FY1627 Jul 2015-0.2%+7.6%+4.7%4.6×
Q4 FY1520 May 2015+0.9%+6.8%+6.3%2.1×
Q3 FY1524 Feb 2015-2.6%-0.1%-3.0%0.9×
Q2 FY1518 Nov 2014+0.5%+6.8%-0.4%0.4×
Q1 FY1531 Jul 2014-1.7%+5.5%+0.4%0.2×
Q4 FY145 May 2014-1.0%+2.0%+16.6%2.4×
Q3 FY143 Mar 2014+0.7%+0.3%+12.0%0.7×
Q2 FY1415 Nov 2013-1.6%+1.5%+5.4%0.1×
Q1 FY143 Aug 2013-0.4%+2.7%-3.8%0.1×
Q4 FY138 May 2013+1.0%+0.3%+4.1%0.2×
Q3 FY1326 Feb 2013-0.8%+0.4%+7.9%2.9×
Q2 FY1331 Oct 2012+0.1%+0.5%-0.3%0.4×
Q1 FY1326 Jul 2012+0.9%+0.1%-3.7%0.3×
Q4 FY124 May 2012+0.2%-2.1%-2.1%0.3×
Q3 FY1223 Feb 2012-1.3%-4.2%-6.3%0.6×
Q2 FY1216 Nov 2011-0.6%-4.9%-4.6%0.2×
Q1 FY1228 Jul 2011+0.9%-2.1%+3.0%0.1×
Q4 FY1126 Apr 2011+3.4%+3.7%+0.8%11.0×
Q3 FY1116 Feb 2011+3.1%+2.9%+3.4%9.5×
Q2 FY1125 Oct 2010-0.3%+0.5%+3.2%0.2×
Q1 FY1119 Jul 2010-0.2%-3.7%-7.2%1.4×
Q4 FY1027 Apr 2010-0.4%+2.3%+0.4%0.2×
Q3 FY1024 Feb 2010-1.3%+0.7%+9.2%15.5×
Q2 FY1027 Oct 2009+1.0%+1.8%+2.0%0.6×
Q1 FY1022 Jul 2009+1.2%+9.7%+15.3%1.8×
Q4 FY0928 Apr 2009-0.2%+6.1%+17.9%0.1×
Q3 FY0917 Feb 2009-0.9%-1.2%-1.2%54.3×
Q2 FY0923 Oct 2008-5.8%-0.2%+9.1%0.2×
Q1 FY0924 Jul 2008+0.5%+0.2%+6.4%9.8×
Q4 FY0823 Apr 2008-2.2%-3.4%-9.5%0.4×
Q3 FY0821 Feb 2008-1.2%+0.6%-18.1%0.4×
Q2 FY0830 Oct 2007-2.1%-3.2%-5.9%12.5×
Q1 FY0817 Jul 2007-2.7%-6.9%-8.7%0.3×
Q4 FY0717 Apr 2007-2.1%+3.0%+3.9%1.4×
Q3 FY0726 Mar 2007-3.1%-0.2%+2.6%1.8×
Average-0.1%+0.7%+1.1%

Close-to-close from the session before the filing could trade. Day 0 is the first session after it.

Growth · Q3 FY25

Revenue YoY+3.4%
Profit YoY+53.6%
Interest cost YoY-6.7%
Revenue QoQ+12.3%
Profit QoQ+39.8%
CAGR2Y3Y4Y5Y6Y7Y
Revenue-13.1%-13.7%-10.1%-9.4%-8.0%-6.7%
Profit-11.0%-15.1%-11.0%-17.9%-3.5%-1.2%

Key data

Open3,170.00
Day range3,170.00 – 3,216.50
52-week range2,758.20 – 4,650.00
From 52w high-31.1%
RSI (14)51.0
ATR (14)78.31
Volume8.5K
Avg volume (20D)38.3K
Rel volume0.22×
Volatility (1Y)22.8%
Turnover₹2.7Cr
Traded value (NSE)₹2.7Cr
VWAP3,200.30
SMA 50 / 2003,107.18 / 3,359.26
Price band20%

Delivery percentage

Latest · 20 Nov 202650.1%
20-day avg47.3%
1-year avg56.2%
Percentile (own history)13th
Range2.4–100.0%
Sessions3,628

Over the last 20 sessions SANOFI settled 47.3% of its traded quantity, which is above average for an NSE equity. Its one-year average is 56.2%, so recent sessions are running 8.9 points lower than usual. The latest session ranks higher than 13% of the 3,628 sessions on record for it.

What delivery percentage measuresScan the whole market on delivery

Dividends, deals & holders

Dividend yield3.84%
Dividend, trailing 12M₹123.00
Paid every year for7 yr
Shareholders80.1K · +0.1% QoQ
Net bulk deals, 30D0.00%
Block deals, 30D₹0
Last bulk buy57 days ago

Performance returns

1D1W1M3M6M1Y
Price+0.11%-2.89%+13.25%-3.46%+0.47%-30.01%

Valuation

Market cap₹7,384 Cr
Market cap (NSE)₹7,384 Cr
Free-float cap₹2,924 Cr
P/E (TTM)20.3
P/E (NSE)20.2
EPS (TTM)158.27
P/B8.9
Net margin (TTM)20.0%
Other income / PBT3.9%
ROE40.3%
Debt / equity0.00
Shares outstanding2.30Cr
Listed19 May 2003

Ownership

Promoter60.40%
Promoter Δ QoQ0.00 pp
Public39.60%
FII5.73%
DII19.41%
Pledged0.00%

Quarterly results · consolidated

Q4 FY24Q1 FY25Q2 FY25Q3 FY25
Revenue (₹ Cr)732.4463.5524.0514.9
YoY chg—-34.4%-26.7%-25.8%
Net profit (₹ Cr)136.6103.282.291.3
YoY chg—-16.0%-45.9%-33.7%
Net margin18.7%22.3%15.7%17.7%
EPS59.3144.8135.6939.60

Shareholding over time

By quarter

30 Sept 2026 · promoter 60.40% · public 39.60%
30 Sept 2021: promoter 60.40%31 Dec 2021: promoter 60.40%31 Mar 2022: promoter 60.40%30 Jun 2022: promoter 60.40%30 Sept 2022: promoter 60.40%31 Dec 2022: promoter 60.40%31 Mar 2023: promoter 60.40%30 Jun 2023: promoter 60.40%30 Sept 2023: promoter 60.40%31 Dec 2023: promoter 60.40%31 Mar 2024: promoter 60.40%30 Jun 2024: promoter 60.40%30 Sept 2024: promoter 60.40%31 Dec 2024: promoter 60.40%31 Mar 2025: promoter 60.40%30 Jun 2025: promoter 60.40%30 Sept 2025: promoter 60.40%31 Dec 2025: promoter 60.40%31 Mar 2026: promoter 60.40%30 Jun 2026: promoter 60.40%30 Sept 2026: promoter 60.40%
2021-092026-09
  • Promoter
  • Public and others
Promoter
60.40%
Public
39.60%
Promoter change
0.00 pp
Filed
20 Oct 2026
FII
5.73%
DII
19.41%
Promoter pledged
0.00%

Who the public is

Mutual funds
8.62%

-0.52 pp QoQ

Insurance
10.78%

+0.05 pp QoQ

FPI
5.73%

+0.04 pp QoQ

Retail ≤ ₹2L
11.50%

+0.45 pp QoQ

HNI > ₹2L
0.42%

+0.09 pp QoQ

NRI
1.02%

+0.01 pp QoQ

Bodies corporate
0.82%

-0.09 pp QoQ

Shareholders
80,089

+0.1% QoQ

Major holders

As of 30 Sept 2026
HolderTypeHolding
HOECHST GMBHPromoter · Corporate45.18%
Sanofi Healthcare India Private LimitedPromoter · Corporate15.20%
LIFE INSURANCE CORPORATION OF INDIA - P & GS FundInsurance5.95%
NIPPON LIFE INDIA TRUSTEE LTD- A/C NIPPON INDIA GROWTH MID CAP FUNDMutual fund4.17%
GENERAL INSURANCE CORPORATION OF INDIAInsurance2.56%
ADITYA BIRLA SUN LIFE MUTUAL FUND - ADITYA BIRLA SUN LIFE LARGE CAP FUNDMutual fund2.04%
BAJAJ LIFE INSURANCE LIMITEDInsurance1.44%
SBI CONTRA FUNDMutual fund1.09%
SANOFIPromoter · Corporate0.02%

Every promoter-group member, and each public holder above 1%, as filed.

Promoter and public shares of total equity, from the pattern filed each quarter. Institutional, pledge and public-breakdown figures come from the filing's XBRL, which most filings before Sep-2021 lack, so they are absent there rather than zero. Changes are against the previous filing.

Dividends

since 10 Apr 2012 CSV
Financial yearPaymentsDeclaredAdjusted
FY2026-272₹123.00₹123.00
FY2025-262₹192.00₹192.00
FY2024-251₹117.00₹117.00
FY2023-242₹427.00₹427.00
FY2022-232₹683.00₹683.00
FY2021-221₹365.00₹365.00
FY2020-211₹349.00₹349.00
FY2019-201₹66.00₹66.00
FY2018-192₹71.00₹71.00
FY2017-182₹68.00₹68.00
FY2016-172₹65.00₹65.00
FY2015-162₹53.00₹53.00
FY2014-152₹45.00₹45.00
FY2013-142₹39.00₹39.00
FY2012-132₹33.00₹33.00
Ex-dateRecord dateDeclaredAdjusted
5 Nov 20265 Nov 2026₹75.00₹75.00
22 Apr 2026—₹48.00₹48.00
7 Nov 2025—₹75.00₹75.00
25 Apr 2025—₹117.00₹117.00
3 May 2024—₹117.00₹117.00
7 Mar 2024—₹50.00₹50.00
28 Apr 2023—₹377.00₹377.00
5 Aug 2022—₹193.00₹193.00
12 Apr 2022—₹490.00₹490.00
19 Apr 2021—₹365.00₹365.00
29 Jun 2020—₹349.00₹349.00
25 Apr 2019—₹66.00₹66.00
6 Aug 2018—₹18.00₹18.00
26 Apr 2018—₹53.00₹53.00
31 Jul 2017—₹18.00₹18.00
25 Apr 2017—₹50.00₹50.00
4 Aug 2016—₹18.00₹18.00
13 Apr 2016—₹47.00₹47.00
29 Jul 2015—₹18.00₹18.00
16 Apr 2015—₹35.00₹35.00
31 Jul 2014—₹10.00₹10.00
16 Apr 2014—₹35.00₹35.00
5 Aug 2013—₹10.00₹10.00
5 Apr 2013—₹29.00₹29.00
2 Aug 2012—₹4.00₹4.00
10 Apr 2012—₹29.00₹29.00

Rupees per share by ex-date, from NSE’s corporate actions; the record date is who was paid. Declared is the figure in the filing; adjusted restates it for splits and bonuses since, on the same basis as the price chart. Financial years run April to March.

Book closures & record dates

Loading…

NSE's corporate-action calendar: who held the stock on the record date, or through the book-closure window, was entitled to the dividend, bonus, split or rights named.

Insider trades

Insiders net, 30d
₹0
Insiders net, 90d
₹0
Promoters net, 90d
₹0
Insider buyers, 90d
0
Last promoter buy
none on record
Disclosures on record
2
0 open-market of the newest 2
By year

No open-market insider trades among the recent disclosures.

SEBI insider-trading disclosures, equity only. Dated by the day NSE broadcast them; the trade itself is often weeks earlier. The figures count promoters, directors and KMPs buying or selling on the exchange — not ESOPs, gifts, transfers within the promoter group or pledges. Stake is the holding after, as filed; the change beneath it scales that by the share counts before and after. Regulation is the PIT clause cited, and “told” the day the insider informed the company.

How the insider figures are countedPromoters buying in the open market, market-wideEvery stock on this session

Filings

CSV
Loading…

Bulk & block deals · 24 Sept 2026

CSV
8 of 8 deals
By year
DateDealClientQuantityPriceValue
24 Sept 2026Sell · block, also bulkHOECHST GMBH35.00L3,052.00₹1,068.2Cr
24 Sept 2026Buy · block, also bulkSANOFI HEALTHCARE INDIA PRIVATE LIMITED35.00L3,052.00₹1,068.2Cr
3 Oct 2022Sell · blockISHARES CORE EMERGING MARKETS MAURITIUS CO18.9K5,780.80₹10.9Cr
3 Oct 2022Buy · blockISHARES CORE MSCI EMERGING MARKETS ETF18.9K5,780.80₹10.9Cr
3 Oct 2022Sell · blockISHARES INDIA SC MAURITIUS COMPANY2.2K5,780.80₹1.3Cr
3 Oct 2022Buy · blockISHARES MSCI INDIA SMALL-CAP ETF2.2K5,780.80₹1.3Cr
19 Dec 2007Sell · bulkMORGAN ST GROWTH FUND · as AVENTIS2.49L1,000.00₹24.9Cr
19 Dec 2007Buy · bulkRELIANCE CAPITAL TRUSTEE CO.LTD. · as AVENTIS1.50L1,000.00₹15.0Cr

A bulk deal is a client trading over 0.5% of the company’s shares in a day; a block deal is one large trade in the separate block window. Quantities and prices are as NSE published them, not split-adjusted.

Every stock on this session →

Takeover-code disclosures

Loading…

Filed under SEBI’s takeover regulations when a holding crosses 5% of the company, and again with every 2% it moves after that. Shares and percentages as filed.

Every stock on this session →

Short selling, lending & margin

Loading…

Shares sold short on the day, as brokers reported them to NSE at the close. As reported, not split-adjusted.

Exchange surveillance

20 Nov 2026

No surveillance measure applies to SANOFI.

Price band: 20% · not in the F&O ban.

From NSE’s daily surveillance, price-band and position-limit files. A stock enters the F&O ban when open interest passes 95% of its market-wide position limit and leaves it below 80%; until then no new positions can be opened. CSV: measures · band changes.

Every stock on this session →

Financials · quarterly statement

₹ crore, as filed
By year
 Q1 FY24Q2 FY24Q3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25
Revenue from operations706.1714.6693.9732.4463.5524.0514.9
Other income15.711.812.06.54.82.35.9
Total income721.8726.4705.9738.9468.3526.3520.8
Total expenses538.4516.5517.1523.8357.2413.7406.6
└ Finance costs0.70.30.40.30.40.40.4
└ Depreciation9.89.910.210.09.09.09.6
Profit before tax183.4209.9188.8188.492.1112.6122.2
Tax expense60.557.951.151.823.930.430.9
Net profit122.9151.9137.7136.6103.282.291.3
EPS53.3765.9559.7959.3144.8135.6939.64
Net margin17.41%21.26%19.84%18.65%22.27%15.69%17.73%
PBT margin25.97%29.37%27.21%25.72%19.87%21.49%23.73%
Tax rate32.99%27.60%27.07%27.49%25.95%27.00%25.29%

A audited · R restated by a later filing · negatives in parentheses. EPS and the share count are restated onto the same split-adjusted basis as the price chart, so they can be read against it; every rupee figure is exactly as filed. The balance sheet and cash flow arrive only with the half-year and annual filings, and are in their own section below. Latest filed 28 Feb 2025.

Balance sheet & cash flow · half-yearly

₹ crore, as filed
By year

Balance sheet

 Q1 FY24Q3 FY24Q1 FY25Q3 FY25
Total assets1,497.61,714.81,360.31,611.8
Current assets1,032.91,248.0876.81,264.3
└ Cash & equivalents434.1394.5248.2283.8
└ Other bank balances14.012.012.011.0
└ Current investments0.00.00.00.0
└ Trade receivables125.6131.7179.8230.0
└ Inventories411.6663.8356.2499.8
Total equity724.21,015.2684.6860.6
└ Attributable to owners724.21,015.2684.6860.6
└ Share capital23.023.023.023.0
Borrowings0.00.00.00.0
└ Current0.00.00.00.0
└ Non-current0.00.00.00.0
Trade payables330.2291.5232.3406.3
Current liabilities724.7651.3639.6719.2
Total liabilities773.4699.6675.7751.2
Net debt(448.1)(406.5)(260.2)(294.8)
Debt / equity0.000.000.000.00
Current ratio1.431.921.371.76

Cash flow, year to date

 Q1 FY24Q3 FY24Q1 FY25Q3 FY25
Operating cash flow259.3230.4360.4461.5
└ Capex(14.8)(34.3)(23.1)(36.4)
Free cash flow244.5196.1337.3425.1
Investing cash flow43.437.5(12.1)(19.2)
Financing cash flow(873.5)(878.3)(388.3)(553.0)
└ Dividends paid(868.3)(868.3)(384.6)(384.6)
└ Buybacks0.00.00.00.0
Net change in cash(570.8)(610.4)(40.0)(110.7)

From the half-year and annual results filings: the balance sheet from September 2022, the cash flow from September 2020. Those are when NSE’s XBRL began to carry each statement; earlier filings have it only in the attached PDF. Cash flow columns are year to date, so an H1 column covers April to September and an FY column the full year. Outflows are in parentheses. Net debt is borrowings less cash, bank balances and current investments; for banks, NBFCs and insurers it, debt to equity and the current ratio are left blank because their statements are not built that way.

Announcements & board meetings

Loading…

As the company filed them with NSE, newest first. Board meetings are dated by the meeting, which is usually a week or more after the intimation.

Every stock on this session →

SANOFI at a glance

  • SANOFI closed at ₹3,206.1 on 20 Nov 2026, +0.11% on the day, -30.0% over one year, 31.1% below its 52-week high of ₹4,650.
  • Delivery was 50.1% of traded quantity on 20 Nov 2026, the 13th percentile of its own 3,628 sessions with a reading (20-session average 47.3%, 1-year average 56.2%).
  • Market capitalisation is ₹7,384 crore at a trailing P/E of 20.3 (trailing EPS ₹158.27).
  • Q3 FY25 results (consolidated, filed 27 Feb 2025): revenue ₹515 crore (-25.8% year on year), net profit ₹91 crore (-33.7%); the price moved +0.5% on the first session after.
  • Promoters held 60.40% at 30 Sept 2026, unchanged on the previous filing.
  • Q3 FY27 results are expected between 23 Feb 2027 and 27 Feb 2027, going by past filing dates — an estimate, not an announcement.

About

Macro sectorHealthcare
Basic industryPharmaceuticals
ISININE058A01010
SeriesEQ
Listed19 May 2003
Former symbolsAVENTIS (until 11 Jul 2012), HOECHST (until 19 May 2003)
Former namesAventis Pharma Limited (until 11 Jul 2012)
NSE market cap · 17 Nov 2026₹7,425 Cr
Free-float market cap (NSE)₹2,926 Cr
Shares outstanding (NSE)2.30Cr
History from19 May 2003
Sessions5,838
Turnover rank#891

Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 20 Nov 2026.